Bamlanivimab, Drugs Monitor

(17 May 2021) Bamlanivimab- 94.4 % showed improvement in 24-72 hrs

Bamlanivimab Use in a Military Treatment Facility https://doi.org/10.1093/milmed/usab188 Of the COVID-19 patients who were given the option of a bamlanivimab infusion, 40 accepted and 6 did not (40/46, 86.9%). Thirty-six of 40 patients in the treatment group were contacted within… Continue reading

(22 Jan 2021) Bamlanivimab-associated with a statistically significant reduction in SARS-CoV-2 viral load at day 11

January 28, 2021

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial https://doi.org/10.1001/jama.2021.0202 NCT04427501- Among the 577 patients who were randomized and received an infusion (mean age, 44.7… Continue reading "(22 Jan 2021) Bamlanivimab-associated with a statistically significant reduction in SARS-CoV-2 viral load at day 11"

Tag: Bamlanivimab

(17 May 2021) Bamlanivimab- 94.4 % showed improvement in 24-72 hrs

(22 Jan 2021) Bamlanivimab-associated with a statistically significant reduction in SARS-CoV-2 viral load at day 11